- Home
- MCRB vs LCUT Comparison
MCRB vs LCUT Comparison
Compare MCRB & LCUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRB
- LCUT
- Stock Information
- Founded
- MCRB 2010
- LCUT 1945
- Country
- MCRB United States
- LCUT United States
- Employees
- MCRB N/A
- LCUT N/A
- Industry
- MCRB Biotechnology: Pharmaceutical Preparations
- LCUT Industrial Machinery/Components
- Sector
- MCRB Health Care
- LCUT Consumer Discretionary
- Exchange
- MCRB Nasdaq
- LCUT Nasdaq
- Market Cap
- MCRB 103.7M
- LCUT 90.8M
- IPO Year
- MCRB 2015
- LCUT 1991
- Fundamental
- Price
- MCRB $12.09
- LCUT $4.86
- Analyst Decision
- MCRB Hold
- LCUT Buy
- Analyst Count
- MCRB 4
- LCUT 2
- Target Price
- MCRB $73.67
- LCUT $5.50
- AVG Volume (30 Days)
- MCRB 109.0K
- LCUT 149.1K
- Earning Date
- MCRB 08-12-2025
- LCUT 08-07-2025
- Dividend Yield
- MCRB N/A
- LCUT 3.36%
- EPS Growth
- MCRB N/A
- LCUT N/A
- EPS
- MCRB 8.98
- LCUT N/A
- Revenue
- MCRB N/A
- LCUT $680,795,000.00
- Revenue This Year
- MCRB N/A
- LCUT $0.51
- Revenue Next Year
- MCRB N/A
- LCUT $1.90
- P/E Ratio
- MCRB $1.50
- LCUT N/A
- Revenue Growth
- MCRB N/A
- LCUT N/A
- 52 Week Low
- MCRB $6.53
- LCUT $2.89
- 52 Week High
- MCRB $30.60
- LCUT $9.03
- Technical
- Relative Strength Index (RSI)
- MCRB 66.74
- LCUT 62.25
- Support Level
- MCRB $10.67
- LCUT $4.97
- Resistance Level
- MCRB $12.84
- LCUT $5.44
- Average True Range (ATR)
- MCRB 1.09
- LCUT 0.39
- MACD
- MCRB 0.34
- LCUT 0.08
- Stochastic Oscillator
- MCRB 85.98
- LCUT 79.12
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
About LCUT Lifetime Brands Inc.
Lifetime Brands Inc is a U.S. based company that designs, sources, and sells branded kitchenware, tableware, and other products used in the home and markets its products under brands such as Farberware, KitchenAid, Mikasa, and others. The company markets and sells its products principally on a wholesale basis to retailers. It also markets and sells a limited selection of its products directly to consumers through its Pfaltzgraff, Mikasa, Fred, and Friends, Built NY, and others. Its products include kitchen tools, gadgets, cutlery, dinnerware, and glassware. The segments of the company are the U.S. and International. It derives a majority of its revenue from the U.S. segment. The company derives maximum revenue from Kitchenware products.